Kenyans247 Forum

Welcome, Guest: Join Kenyans247 LOGIN!

Stats: 224 Members, 11,371 topics and 65 posts Date: Sunday 05 April 2020 at 03:09 PM
TrendingRecentNewestClassifiedDirectoryLivescoresLive Kenyan TVLive Kenyan Radio

Coronavirus: NAFDAC Approves Production Of Chloroquine For Clinical Trials

Kenyans247 / Kenyans247 / General / Naija Forums / Coronavirus: NAFDAC Approves Production Of Chloroquine For Clinical Trials (15 View's)

Volkswagen Suspends Production As Coronavirus Hits Sales Govt Announces Random Coronavirus Screening Live News/europe Coronavirus Live Updates: Worldwide Death Toll Surges Past 11k Your Coronavirus Emergency Kit: How To Work From Home Effectively
(Go Down) (» Reply topic)
Coronavirus: NAFDAC Approves Production Of Chloroquine For Clinical Trials by Kenyans247(m): Sat 21, March, 2020 10:14am
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in tackling COVID-19.

Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.

She, however, pointed out that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.

“In the case of Chloroquine, it has been demonstrated in the literature and with clinical research which is still ongoing, that Chloroquine is superior to the Placebo.

“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.

“Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.

She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets, adding that a drug company has been given an approval to produce chloroquine in batches

“Right now, we have asked one company to make a batch of Chloroquine for the purpose of clinical trial,” Adeyeye added.

The NAFDAC DG also urged Nigerians not to use Chloroquine as anti-malaria.

“Nobody should use chloroquine as anti-malaria because of the resistance that has been proven to develop in the past after the use of chloroquine in the population.

(» Reply topic) (» Go Up)

Recommended for you

» 'd' Word Rears Head As Coronavirus-hit Markets Brace For Recession » Armed With Lessons From Ebola, Africa Braces For Coronavirus Surge » Sanofi, Regeneron Start Testing Arthritis Drug To Fight Coronavirus » How Kenyan Sports Personalities Are Keeping Busy During Coronavirus Shutdown
Viewing this topic:
1 guest(s) viewing this topic

Sections: Kenyans247 ads, International Forum, Autos, Romance, Politics, Webmasters, Phones, Art, Graphics & Video, Programing, Education, Lifestyle, Social Media/K247 Chit-Chat, Celebrities, Music/Radio, Photography, Somalia Forum, Ugandan Forum, Burundi Forum, South Sudan Forum, Tanzania Forum,

Kenyans247 - Copyright © 2019 - 2020 Sande Kennedy. All rights reserved. See How To Advertise.
Disclaimer: Every Kenyans247 member is solely responsible for anything that he/she posts or uploads on Kenyans247.